FindTrial
Sign In

To assess risk of high BP in pregnant women.

Risk approach in prevention of preeclampsia: a prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/03/023799
Enrollment
120
Registered
2020-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O14- Pre-eclampsia

Interventions

None listed

Sponsors

Kasturba Medical College Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the patients booked at 12 or less than 12 weeks who underwent NT scan in Kasturba hospital, Manipal during the study period.

Exclusion criteria

Exclusion criteria: Patients allergic to aspirin and heart disease complicating pregnancy.

Design outcomes

Primary

MeasureTime frame
To assess risk for pre eclampsia in pregnant women at 12 weeksTimepoint: To assess risk for pre eclampsia in pregnant women at 12 weeks of gestation—

Secondary

MeasureTime frame
To observe the perinatal outcome in patients having clinical, biochemical and ultrasonological risk factors for pre-eclampsia taking aspirin 75mg at 12 to 16 weeks of gestationTimepoint: After delivery of the patient.—

Countries

India

Contacts

Public ContactPranadeep Reddy Inukollu

Manipal academy of higher education

pranadeep_inukollu@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026